(Reuters) -Agilon Health is aiming for a valuation of up to $9 billion in its initial public offering (IPO), the healthcare platform said on Wednesday, joining a clutch of companies looking to cash in on the record run in U.S. capital markets.
The company said it planned to raise more than $1 billion in its IPO by selling 46.6 million shares at a price range of $20 and $23 per share.
Founded in 2016, Agilon health provides a care platform for primary care physicians.
The company will list on the New York Stock Exchange under the symbol “AGL,” it said in a filing.
JP Morgan, Goldman Sachs and BofA are among the underwriters for the offering.
Reporting by Niket Nishant and Mrinalika Roy in Bengaluru; Editing by Aditya Soni
Disclaimer: The views expressed in this article are those of the author and may not reflect those of Kitco Metals Inc. The author has made every effort to ensure accuracy of information provided; however, neither Kitco Metals Inc. nor the author can guarantee such accuracy. This article is strictly for informational purposes only. It is not a solicitation to make any exchange in commodities, securities or other financial instruments. Kitco Metals Inc. and the author of this article do not accept culpability for losses and/ or damages arising from the use of this publication.
Read More: Healthcare platform Agilon targets valuation of up to $9 billion in U.S. IPO
